Literature DB >> 31328529

The Value of Physical Symptoms in Screening For Posttraumatic Stress Disorder in the Military.

Kristin Graham1, Amelia Searle1, Miranda Van Hooff1, Ellie Lawrence-Wood1, Alexander McFarlane1.   

Abstract

Physical symptoms are highly comorbid with posttraumatic stress disorder (PTSD). As PTSD is underdiagnosed, this study explored the value of self-reported physical symptoms in screening for 30-day PTSD in military personnel. Two physical symptom scales were constructed using items from a 67-item health symptom checklist, clinical interviews were used as the diagnostic reference standard, and diagnostic utility of physical symptoms was compared with the current gold standard screen, the PTSD checklist (PCL). Receiver operating characteristic analyses showed that both a 9-item and a 10-item physical symptom scale were of value in predicting PTSD (areas under the curve 0.81 and 0.85). Importantly, two thirds of PTSD positive personnel missed by the PCL were captured with physical symptoms scales, and when physical symptoms were added to the PCL, prediction was improved (areas under the curve 0.90 to 0.92). Our findings highlight the value of including assessing physical symptoms in PTSD screening.

Entities:  

Keywords:  military; physical symptoms; posttraumatic stress; receiver operating characteristic curve

Mesh:

Year:  2019        PMID: 31328529     DOI: 10.1177/1073191119864662

Source DB:  PubMed          Journal:  Assessment        ISSN: 1073-1911


  2 in total

1.  Symptom profiles following combat injury and long-term quality of life: a latent class analysis.

Authors:  Andrew J MacGregor; Amber L Dougherty; Edwin W D'Souza; Cameron T McCabe; Daniel J Crouch; James M Zouris; Jessica R Watrous; John J Fraser
Journal:  Qual Life Res       Date:  2021-04-22       Impact factor: 4.147

2.  Comparing the associations of three psychometric scales at baseline with long-term prognosis of depression over a 10-year period.

Authors:  Ching-I Hung; Chia-Yih Liu; Shih-Chieh Hsu; Ching-Hui Yang
Journal:  Int J Methods Psychiatr Res       Date:  2021-10-29       Impact factor: 4.035

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.